Tolcapone

Drug Profile

Tolcapone

Alternative Names: RO 407592; Tasmar

Latest Information Update: 07 Sep 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Roche
  • Class Antiparkinsonians; Benzophenones; Nitrophenols; Small molecules
  • Mechanism of Action Catechol-O-methyltransferase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Parkinson's disease

Most Recent Events

  • 07 Sep 2009 No development reported - Preregistration for Parkinson's disease in Japan (PO)
  • 23 Feb 2006 Data presented at the 18th World Congress of Neurology (WCN-2005) have been added to the adverse events section
  • 08 Mar 2005 Launched for Parkinson's disease in European Union (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top